Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hillon

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|May 1, 1987
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleedingT Poynard, D Lebrec, P Hillon, et al.
Journal of Clinical Pharmacy and Therapeutics|November 22, 2014
Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinomaL Vadot, M Boulin, B Guiu, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|December 1, 1993
[Bone metastasis of hepatocellular carcinoma. Apropos of 22 cases]J F Maillefert, J Tebib, S Aho, et al.
Journal of Viral Hepatitis|September 29, 2009
The impact of the prevention programme of hepatitis C over more than a decade: the French experienceE Delarocque-Astagneau, C Meffre, F Dubois, et al.
The Analyst|April 24, 2013
Diagnosis of hepatocellular carcinoma in cirrhotic patients: a proof-of-concept study using serum micro-Raman spectroscopyI Taleb, G Thiéfin, C Gobinet, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2005
Is the management of hepatitis C patients appropriate? A population-based studyC Hatem, A Minello, S Bresson-Hadni, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 17, 2017
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetesA L Sberna, B Bouillet, A Rouland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 19, 2015
Type 1 diabetes is not associated with an increased prevalence of hepatic steatosisJ-M Petit, L Pedro, B Guiu, et al.
The New England Journal of Medicine|January 4, 2001
Early administration of vapreotide for variceal bleeding in patients with cirrhosisP Calès, C Masliah, B Bernard, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 3, 2012
Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetesJ M Petit, B Guiu, L Duvillard, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|May 1, 1987
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleedingT Poynard, D Lebrec, P Hillon, et al.
Journal of Clinical Pharmacy and Therapeutics|November 22, 2014
Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinomaL Vadot, M Boulin, B Guiu, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|December 1, 1993
[Bone metastasis of hepatocellular carcinoma. Apropos of 22 cases]J F Maillefert, J Tebib, S Aho, et al.
Journal of Viral Hepatitis|September 29, 2009
The impact of the prevention programme of hepatitis C over more than a decade: the French experienceE Delarocque-Astagneau, C Meffre, F Dubois, et al.
The Analyst|April 24, 2013
Diagnosis of hepatocellular carcinoma in cirrhotic patients: a proof-of-concept study using serum micro-Raman spectroscopyI Taleb, G Thiéfin, C Gobinet, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2005
Is the management of hepatitis C patients appropriate? A population-based studyC Hatem, A Minello, S Bresson-Hadni, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 17, 2017
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetesA L Sberna, B Bouillet, A Rouland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 19, 2015
Type 1 diabetes is not associated with an increased prevalence of hepatic steatosisJ-M Petit, L Pedro, B Guiu, et al.
The New England Journal of Medicine|January 4, 2001
Early administration of vapreotide for variceal bleeding in patients with cirrhosisP Calès, C Masliah, B Bernard, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 3, 2012
Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetesJ M Petit, B Guiu, L Duvillard, et al.
Pageof 9